Better Care Services now offers GLP-1 prescriptions At the close of 2025, 1 in 18 American adults said they were currently taking a GLP-1 for weight loss, diabetes management, or another condition, according to a survey by health policy research firm KFF
What shapes your monthly cost Ro publishes its pricing on its own site, and it moves over time
Finding the appropriate formulation is often challenging, labor intensive, and requires significant amount of API to test in a range of solvent v Overcoming Food Effects, Variability & Solubility for a Non-Opioid Analgesic with Lipid-Based Formulations Poorly soluble oral small molecules often face compounded development risks, including food effects, high dose requirements, variability in exposure and the need for rapid onset
Those who did not discontinue tirzepatide and were on a high maintenance dose lost a mean 18% of their body weight
(2025, February 18)